Epstein Secrets

govt, science, education, philanthropy, and technology to address health challenges facing the U.S. and the world. Day two speakers include former Food and Drug Administration Commissioners Robert Califf, Margaret Hamburg and Mark McClellan, Democratic Reps. Diana DeGette and Tim Ryan, Republican Rep. Fred Upton, World He

rested in delivering something like that as quickly as possible." Reports: Iran's Supreme Leader May Have Transferred Power To Son. Fox News (12/7, McKay, 27.59M) reports that amid speculation "over the declining health of Iran's Supreme Leader, the Grand Ayatollah Ali Khamenei," there were "unconfirm

, govt, science, education, philanthropy, and technology to address health challenges facing the U.S. and the world. Day two speakers include former Food and Drug Administration Commissioners Robert Califf, Margaret Hamburg and Mark McClellan, Democratic Reps. Diana DeGette and Tim Ryan, Republican Rep. Fred Upton, World He

e Transferred Power To Son. Fox News <https://www.foxnews.com/world/is-irans-supreme-leader-preparing-to-designate-his-son-as-the- successor> (12/7, McKay, 27.59M) reports that amid speculation "over the declining health of Iran's Supreme Leader, the Grand Ayatollah Ali Khamenei," there were "unconfirm

govt, science, education, philanthropy, and technology to address health challenges facing the U.S. and the world. Day two speakers include former Food and Drug Administration Commissioners Robert Califf, Margaret Hamburg and Mark McClellan, Democratic Reps. Diana DeGette and Tim Ryan, Republican Rep. Fred Upton, World He

ested in delivering something like that as quickly as possible." Reports: Iran's Supreme Leader May Have Transferred Power To Son. Fox News (12/7, McKay, 27.59M) reports that amid speculation "over the declining health of Iran's Supreme Leader, the Grand Ayatollah Ali Khamenei," there were "unconfirm

ch Times (11/30, Nguyen Ly). US Panel Backs First-Of-A-Kind COVID-19 Pill From Merck The Associated Press (11/30, Perrone) reported that a panel of Food and Drug Administration (FDA) health advisers voted 13-10 in support of Merck's new COVID-19 pill, molnupiravir, stating that the antiviral drug's benefits outweigh its ri

dn't be used in vaccinated people, who weren't part of Merck's research and haven't been shown to benefit!' The Wall Street Journal (11/30, Hopkins, McKay) reported that according to a final analysis, the drug was found to be 30% effective at reducing the risk of hospitalization and death in high-risk